BinaxNOW® Tests are easy-to-use-and-interpret rapid immunochromatographic tests (ICT) that detect specific analytes in clinical specimens.  Inverness Medical Innovations has successfully developed BinaxNOW® Tests for bacteria, viruses and parasites. Use of the BinaxNOW® Tests enable early and accurate identification of disease-causing pathogens, thus facilitating the implementation of appropriate and cost-effective treatment plans.

The development of antibiotic resistance among various strains of organisms is a growing problem that concerns many scientists and clinicians worldwide.  One of the big advantages of the BinaxNOW® diagnostic tests is that, by rapidly identifying causative organisms, they can help prevent empiric use of broad-spectrum antibiotics, which encourages antibiotic resistance, and help assure use of pathogen-specific antibiotics which mitigates development of resistance.

The BinaxNOW® line of respiratory tests help address the huge medical burden posed by pneumonia by helping to determine if the pneumonia is caused by S. pneumoniae, Legionella or other bacteria. For example, these tests can help assure that patients get the appropriate antibiotic treatment, thereby reducing severity, duration of illness, complications, spread of disease, and mortality, and improving patient outcomes.

To find out more about Binax products go to www.binax.com

BinaxNOW® Filariasis Test
BinaxNOW® Malaria Test
BinaxNOW® RSV Test
BinaxNOW® Strep A Test
BinaxNOW® Streptococcus pneumoniae
BinaxNOW® Influenza A & B
BinaxNOW® Legionella
EIA Legionella